You just read:

U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes

News provided by

Eli Lilly and Company

May 31, 2016, 10:01 ET